4.6 Review

Recent developments in natural biopolymer based drug delivery systems

Journal

RSC ADVANCES
Volume 13, Issue 33, Pages 23087-23121

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d3ra03369d

Keywords

-

Ask authors/readers for more resources

Targeted delivery of drug molecules to diseased sites using biopolymer-based drug delivery systems (DDS) is an effective approach to achieve good therapeutic results and minimize toxicity to healthy cells. Biopolymers, such as cellulose chitosan, starch, silk fibroins, collagen, albumin, gelatin, alginate, agar, proteins, and peptides, have shown potential applications in DDS due to their biodegradability, compatibility, non-toxicity, non-immunogenicity, and high drug loading ratio. Various synthetic techniques and formulations have been reported for designing and fabricating DDS for different delivery systems.
Targeted delivery of drug molecules to diseased sites is a great challenge in pharmaceutical and biomedical sciences. Fabrication of drug delivery systems (DDS) to target and/or diagnose sick cells is an effective means to achieve good therapeutic results along with a minimal toxicological impact on healthy cells. Biopolymers are becoming an important class of materials owing to their biodegradability, good compatibility, non-toxicity, non-immunogenicity, and long blood circulation time and high drug loading ratio for both macros as well as micro-sized drug molecules. This review summarizes the recent trends in biopolymer-based DDS, forecasting their broad future clinical applications. Cellulose chitosan, starch, silk fibroins, collagen, albumin, gelatin, alginate, agar, proteins and peptides have shown potential applications in DDS. A range of synthetic techniques have been reported to design the DDS and are discussed in the current study which is being successfully employed in ocular, dental, transdermal and intranasal delivery systems. Different formulations of DDS are also overviewed in this review article along with synthesis techniques employed for designing the DDS. The possibility of these biopolymer applications points to a new route for creating unique DDS with enhanced therapeutic qualities for scaling up creative formulations up to the clinical level.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available